Frontlight ResearchEarly access
Trial site
University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP)
- 4running trials
- 6closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer5 trials
- Lung cancer4 trials
- Gastric and oesophageal cancer3 trials
- Melanoma3 trials
- Kidney cancer2 trials
- Liver and biliary tract cancer2 trials
- Metastatic breast cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- and 5 more
- Phase
- Phase 14 trials
- Phase 1/23 trials
- Phase 23 trials
- Status
- Terminated4 trials
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Pfizer6 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Arsenal Biosciences, Inc.1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Kidney cancer1 recruiting
Closed trials
Terminated
Completed
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Completed
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
Terminated
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 17 Nov 2026